Sandy Hathaway

Exit3x joins forces with corporate innovation teams to create operating startups and attack new markets together. We achieve “unfair advantage” through corporate-startup collaborations that work. We are highly experienced venture architects, operational founders, product creators, business strategists, fundraisers, company builders, and M&A participants — innovating on B2B and B2C business models, technologies and service solutions.

AVARI was a recommendation engine that used browsing behavior data and machine learning to personalize campaigns in real-time. A separately branded pivot from RetentionGrid, our lead investors & several angels re-invested €700K in AVARI in Nov. 2014, which was acquired by programmatic advertising technology and ad space platform company LiveIntent in Oct. 2015.

RetentionGrid is a data-driven, automated customer retention solution serving more than 11,000 e-commerce businesses in 63 countries with 25 million consumers in 188 countries. After rapidly growing to thousands of B2B users and being recommended as a top application by e-commerce platform market leader Shopify, 5 months after launch we raised a €520K Seed round from Connect Ventures in London and several angels internationally.

OpenMedTech facilitates the flow of appropriate medical technology to underserved patient populations worldwide.

In this position, I was responsible for a variety of marketing, communications, and sales development functions and driving digital initiatives for the global sales & marketing organization. I helped shape the strategic headquarter direction for the global sales and marketing force. I led teams to create investment cases for new subsidiaries. I was on the IT advisory board guiding the infrastructure/CRM strategy.

The BIOTRONIK group is one of the world’s leading companies in the development, manufacture, and sales of medical devices for cardiology, cardiac electrophysiology and vascular intervention. In this position, I managed the initiative to find drug eluting stent (DES) startup and development partners. The goals were to close a significant unexpected portfolio gap, stabilize the corporate image as an innovator in the market and advance internal R&D know-how.

BIOTRONIK Vascular Intervention manufactures and distributes therapies for coronary and peripheral vascular disease including absorbable, drug eluting and bare metal stent systems as well as balloons, guidewires and catheters. In this role, I evaluated collaborations between field sales and HQ marketing to define a digital transformation strategy that would increase effectiveness. I led development of a business unit intranet that became the foundation for the company-wide internal communications platform.

The BIOTRONIK group is one of the world’s leading companies in the development, manufacture, and sales of medical devices for cardiology and cardiac electrophysiology. In this position, I created and launched a program of customer innovation forums to collect feedback for product development and established a new "Open Innovation Process" for collecting and managing incoming product ideas from physicians.

In this position, I worked in the Medtronic Endovascular business unit to establish the vision, strategy, and objectives of the global thoracic stent graft business. I provided guidance for all aspects of products (customer inputs, concept definition, development, validation, clinical research, product launch, lifecycle management, line extensions, new applications), managed budgets, oversaw research, and coordinated marketing strategies and teams.

During this one-year assignment, I provided product marketing support to customers, stimulated sales, initiated market development projects and aligned efforts across countries in Western Europe and Emerging Markets. For example, I acted as company liaison to physicians conducting a Medtronic-sponsored, multi-center European clinical study exploring the viability of aorto-uni-iliac stent grafts for the emergency repair of ruptured aortic aneurysms.

In this position, I was involved in the downstream marketing and international launch of two product lines.

In this position, I was responsible for the Talent Stent Graft business, treating AAA, AUI and thoracic aortic disease. I identified market trends and areas for product development potential, planned the long term product strategy, implemented launches and competitive marketing campaigns, and engaged with customers at events.

In this position, I participated in product launch plans, sales promotions, research, and supported marketing managers.

In this position, I was involved in sales force support, report creation, order processing, and project leader for complex global product recall.

In this position, I was involved in the hiring, training, orientation of staff as well as developing events and care programs for residents.

Sales Force Strategy, Sales & Negotiations, Executive Leadership, Pricing Strategy, Marketing Leadership, High Impact Coaching and Feedback, Market-Driven Product Development, Strategic Market Management